Supply of DNA/RNA UD Indexes (Sets B, C, D)

The contract is for the supply of unique dual indexes for multiplexing DNA and RNA samples, specifically Sets B, C, and D, required for high-throughput sequencing applications. These indexes are critical for enabling efficient sample pooling while maintaining data accuracy and sample integrity during next-generation sequencing workflows. The solicitation is issued under a subcontract structure by the Defense Health Agency Hcd West, with performance located at Tripler Army Medical Center in Honolulu, Hawaii, 96859. The project supports military healthcare research and diagnostic capabilities by ensuring precise sample identification across large-scale genomic analyses. Responses are due by May 7, 2026, at 5:00 PM, with the opportunity posted on May 4, 2026. The NAICS code 325412 identifies the industry as pharmaceutical and medicine manufacturing, reflecting the specialized nature of the reagents being procured. Although no set-aside designation is specified, the requirement is aligned with biomedical research infrastructure supporting Department of Defense medical objectives. The indexes must meet strict quality and traceability standards to ensure compatibility with existing sequencing platforms and to avoid cross-contamination or misassignment in multiplexed runs.